Skip survey header

PROSCA2019 - case 2

Thank You!

Your case challenge

View case
You answered: A
You answered: A
A) Observation - B) PSMA-PET imaging -  C) Salvage EBRT - D) Salvage EBRT + ADT
 

Important considerations on the case according to Nicolas Mottet 



The new EAU 2019 PCa guidelines recommend to perform prostate-specific membrane antigen (PSMA) positron emission tomography (PET) computed tomography (CT) in case PSA > 0.2 ng/ml, if the results will influence subsequent treatment decisions. (strength of recommendation: weak).

In case of PSA only recurrence, imaging is only of value if it leads to a treatment change and therefore to a better outcome. In practice, limited data are available regarding the outcome based on imaging at relapse. Precise detection and location of local recurrences after RP will be needed but not until it has been proven that stereotaxic boost to the recurrence site during salvage RT improves the patient outcome which, so far, remains investigational.


Want to challenge me? I’m happy to discuss these data in more detail during PROSCA on 23-24 October in Paris!
 

Important considerations on the case according to Nicolas Mottet 



The new EAU 2019 PCa guidelines recommend to perform prostate-specific membrane antigen (PSMA) positron emission tomography (PET) computed tomography (CT) in case PSA > 0.2 ng/ml, if the results will influence subsequent treatment decisions. (strength of recommendation: weak).

In case of PSA only recurrence, imaging is only of value if it leads to a treatment change and therefore to a better outcome. In practice, limited data are available regarding the outcome based on imaging at relapse. Precise detection and location of local recurrences after RP will be needed but not until it has been proven that stereotaxic boost to the recurrence site during salvage RT improves the patient outcome which, so far, remains investigational.


Want to challenge me? I’m happy to discuss these data in more detail during PROSCA on 23-24 October in Paris!

Do you have an interesting case of your own?

Up to 3 case reports will be selected by the scientific committee for discussion in the official programme of PROSCA 2019.
 

Submit your case



Join us at PROSCA 2019 to get a full update on prostate cancer and discuss with faculty and peers how 2019 highlights will impact your daily practice.


Reserve your seat